Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Clinical Lung Cancer|September 9, 2022
Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint InhibitorsNicolas Girard, Anna Minchom, Sai-Hong Ignatius Ou, et al.
JTO Clinical and Research Reports|December 6, 2021
Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial ObservationsSebastian Curcean, Lin Cheng, Simona Picchia, et al.
Cancer Chemotherapy and Pharmacology|December 27, 2015
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patientsRajiv Kumar, Shir Kiong Lu, Anna Minchom, et al.
Cancers|March 28, 2024
Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)Shybi Mohamedkhan, Sumeet Hindocha, James de Boisanger, et al.
Cancer Reports (Hoboken, N.J.)|June 26, 2024
A single-centre study evaluating a geriatric screening tool in oncology phase I trial patientsMary Van Zyl, Anne Barell, Bridget Cooley, et al.
Plos One|October 6, 2017
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatmentsAnna Minchom, Parames Thavasu, Zai Ahmad, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2020
Systemic treatment of brain metastases in non-small cell lung cancerSimon Page, Charlotte Milner-Watts, Marco Perna, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapyAnna Minchom, Santiago Viteri, Lyudmila Bazhenova, et al.
The Oncologist|September 15, 2021
Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 TrialAnna Minchom, Aaron C Tan, Erminia Massarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patientsWanyuan Cui, Charlotte Milner-Watts, Hazel O'Sullivan, et al.
Pageof 7